Eloxx Pharmaceuticals, Inc. business relationships
Companies named in Eloxx Pharmaceuticals, Inc.’s 10-K filed 2026-03-17, and public companies whose annual reports name Eloxx Pharmaceuticals, Inc.. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.
- AEO visibility
- 4.7 / 10
- AI naming
- 22 / 100 Top 1% in its category
- Agent readiness
- 35 / 100
- AI adoption
- 0 / 100
Named in Eloxx Pharmaceuticals, Inc.’s annual report 1
“...its March 2024 exclusive license agreement covering the Company's asset ZKN-013 (the "Almirall License Agreement") with Almirall, S.A. ("Almirall"), and does not expect to generate significant revenue unless it obtains marketing approval for and commercializes one or more of its product candidates c...” SEC filing
Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.